Search

Your search keyword '"Yu, Jiyang"' showing total 584 results

Search Constraints

Start Over You searched for: Author "Yu, Jiyang" Remove constraint Author: "Yu, Jiyang"
584 results on '"Yu, Jiyang"'

Search Results

53. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

56. A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity

61. Detection and Decoding for 2D Magnetic Recording Channels with 2D Intersymbol Interference

63. Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL)

64. Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia

66. Selfie Video Stabilization

79. Robust Selfie and General Video Stabilization

82. Parallel accelerated computing architecture for dim target tracking on‐board.

86. Targeting DNA polymerase β elicits synthetic lethality with mismatch repair deficiency in acute lymphoblastic leukemia

87. Data from Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo

88. Supplementary Table S4 from SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging Agents

89. Table S1 from Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma

90. Data from Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma

91. Supplementary Table S2 from Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo

92. Supplementary Methods, Figures and Tables from Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo

93. Data from Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma

94. Supplementary Data from Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma

95. Supplementary Figure from Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma

96. Supplementary Data from SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging Agents

97. Supplementary Data from Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma

Catalog

Books, media, physical & digital resources